Study of GS-3242 in Participants With HIV-1; Substudy-05

NCT07001319 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: GS-3242
DRUG: BVY
DRUG: Standard of Care

Sponsor

Gilead Sciences